Liver Diseases  >>  docetaxel  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
docetaxel / Generic mfg.
NCT00006010: Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer

Completed
2
25
US, Canada
docetaxel, gemcitabine hydrochloride
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI)
Liver Cancer
05/04
04/08
NCT00532441: Erlotinib in Combination With Docetaxel in Advanced Hepatocellular and Biliary Tract Carcinomas

Terminated
2
25
US
Erlotinib, Docetaxel
Gabi Chiorean, MD, Sanofi, OSI Pharmaceuticals
Hepatocellular Carcinoma
08/10
08/10

Download Options